GIVAUDAN SA/ADR (GVDNY) Rating Reiterated by Morgan Stanley

Morgan Stanley reaffirmed their buy rating on shares of GIVAUDAN SA/ADR (OTCMKTS:GVDNY) in a research note published on Tuesday morning.

Other equities research analysts also recently issued reports about the stock. JPMorgan Chase & Co. restated a buy rating on shares of GIVAUDAN SA/ADR in a research report on Tuesday, September 4th. Baader Bank restated a buy rating on shares of GIVAUDAN SA/ADR in a research report on Friday, July 20th. Deutsche Bank restated a neutral rating on shares of GIVAUDAN SA/ADR in a research report on Friday, June 15th. Kepler Capital Markets restated a neutral rating on shares of GIVAUDAN SA/ADR in a research report on Monday, July 23rd. Finally, UBS Group restated a neutral rating on shares of GIVAUDAN SA/ADR in a research report on Friday, August 31st. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. GIVAUDAN SA/ADR presently has an average rating of Hold.

Shares of GVDNY stock opened at $45.98 on Tuesday. GIVAUDAN SA/ADR has a 12-month low of $43.63 and a 12-month high of $50.05.

About GIVAUDAN SA/ADR

Givaudan SA, together with its subsidiaries, manufactures and sells fragrance and flavor products to the food, beverage, consumer goods, and fragrance and cosmetics industries worldwide. The company operates through two divisions, Fragrance and Flavour. The Fragrance division provides fragrance ingredients and active beauty products; fine fragrances, such as signature fragrances and line extensions; and fragrances for use in fabric and personal care, hair and skin care, household and air care, and oral care products.

Read More: Average Daily Trade Volume Explained

Analyst Recommendations for GIVAUDAN SA/ADR (OTCMKTS:GVDNY)

Receive News & Ratings for GIVAUDAN SA/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GIVAUDAN SA/ADR and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply